US Broker Ratings

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Healthcare Innovator with 40% Upside Potential

Establishment Labs Holdings Inc (NASDAQ: ESTA) is capturing investor attention with a compelling growth narrative in the healthcare sector. Specializing in medical devices for breast aesthetic and reconstructive surgeries, this..

Harrow, Inc. (HROW) Stock Analysis: Eye-Catching 99% Potential Upside for Investors

Harrow, Inc. (NASDAQ: HROW) is capturing the attention of investors with its impressive potential upside of nearly 99.44%, according to analyst ratings. As a key player in the healthcare sector,..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 12.97% Potential Upside in the Healthcare Sector

The Pennant Group, Inc. (NASDAQ: PNTG) has emerged as a noteworthy player in the healthcare sector, particularly within medical care facilities. With a market capitalization of $1.16 billion, this dynamic..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: Exploring a 27.81% Potential Upside

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands as a compelling entity in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $976.15 million,..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 91.90% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is catching the attention of investors with its impressive potential upside of 91.90%. As a healthcare player in the biotechnology industry, this biopharmaceutical company is..

GRAIL, Inc. (GRAL) Stock Analysis: Is the 92% Potential Upside Worth the Risk?

GRAIL, Inc. (GRAL), a prominent player in the healthcare sector, specifically in diagnostics and research, has been capturing the attention of investors, largely due to its groundbreaking multi-cancer early detection..

Wave Life Sciences Ltd. (WVE) Stock Analysis: 174% Potential Upside Sparks Investor Interest

Wave Life Sciences Ltd. (WVE) is capturing the attention of investors with its substantial potential upside of 174.48%, as indicated by the average target price of $34.06. This clinical-stage biotechnology..

Artivion, Inc. (AORT) Stock Analysis: Robust Revenue Growth and 37.51% Upside Potential

Investors seeking opportunities in the healthcare sector may find Artivion, Inc. (NYSE: AORT) an intriguing prospect. Specializing in medical devices, this U.S.-based company has demonstrated strong revenue growth, coupled with..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 170% Potential Upside in the Biotech Sector

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology space, is turning heads with an impressive potential upside of 170.76%. With a current stock price of $2.77 and an..

Astrana Health Inc. (ASTH) Stock Analysis: 46% Potential Upside Beckons Investors

Astrana Health Inc. (NASDAQ: ASTH) is emerging as a notable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.37 billion, Astrana..

Beam Therapeutics Inc. (BEAM) Stock Analysis: An Investor’s Guide to Potential 95.89% Upside

Beam Therapeutics Inc. (NASDAQ: BEAM) is a compelling prospect for investors keen on the biotechnology sector, particularly those interested in innovative genetic medicines. With a market capitalization of $2.6 billion,..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Exploring a 100% Upside Potential

Ascentage Pharma Group International (AAPG), a China-based biotechnology firm, is drawing significant attention from investors thanks to its promising pipeline and a compelling potential upside of 100.50%. Specializing in the..

Novavax, Inc. (NVAX) Stock Analysis: Unpacking a 36.68% Potential Upside

As the global race for vaccine innovation continues, Novavax, Inc. (NASDAQ: NVAX) stands out as a key player in the biotechnology sector. With its focus on developing vaccines to prevent..

ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring a 53% Upside Potential

Investors with an eye on the healthcare sector might want to consider ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a noteworthy player in the specialty and generic drug manufacturing industry. With a..

Bausch Health Companies Inc. (BHC)

⚠️ No article content returned.

..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 18.80% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biopharmaceutical company, is making waves in the healthcare sector with its focus on treating autoimmune diseases, including lupus nephritis. With a current market..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a Remarkable 3,054.60% Revenue Growth and 39.74% Upside Potential

Investors with a keen eye on the healthcare sector may find Liquidia Corporation (NASDAQ: LQDA) a compelling addition to their portfolios. As a biopharmaceutical enterprise specializing in treatments for rare..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring the 86% Potential Upside and Analyst Confidence

Schrodinger, Inc. (NASDAQ: SDGR), a pivotal player in the healthcare sector, particularly within the health information services industry, is capturing attention with its innovative approach to drug development and materials..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a 210% Potential Upside in Biotech

For investors seeking opportunities in the healthcare sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling case. With an impressive potential upside of 210.34%, as indicated by analyst ratings, this..

Innoviva, Inc. (INVA) Investor Outlook: Analyzing Growth Potential and a 49.89% Upside

Innoviva, Inc. (NASDAQ: INVA), a burgeoning biopharmaceutical player in the healthcare sector, has caught the attention of investors with its notable growth trajectory and promising market position. Based in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds